• 1
    United States Department of Health and Human Services (USDHHS). The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services; 1990. DHHS Publication No. (CDC) 90-8416.
  • 2
    Peto R, Lopez AD. Mortality from smoking in developed countries: 1950–2000. 2012; Accessed January 25, 2012.
  • 3
    Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Brit Med Bull. 1996; 52:1221.
  • 4
    Rigotti NA. Treatment of tobacco use and dependence. New Engl J Med. 2002; 346:506512.
  • 5
    Preston KL, Silverman K, Higgins ST, et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol. 1998; 66:691696.
  • 6
    Yoon JH, Higgins ST, Bradstreet MP, et al. Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology. 2009; 205:305318.
  • 7
    Alterman AI, Kampman K, Boardman CR, et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend. 1997; 46:7985.
  • 8
    Ehrman RN, Robbins SJ, Cornish JW. Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend. 2001; 62:17.
  • 9
    Stitzer ML, Peirce J, Petry NM, et al. Abstinence-based incentives in methadone maintenance: Interaction with intake stimulant test results. Exp Clin Psychopharmacol. 2007; 15:344350.
  • 10
    Stitzer ML, Petry N, Peirce J, et al. Effectiveness of abstinence-based incentives: Interaction with intake stimulant test results. J Consult Clin Psychol. 2007; 75:805811.
  • 11
    Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive—Effects on drug-use of methadone-maintenance patients. J Consult Clin Psychol. 1992; 60:927934.
  • 12
    Tzilos GK, Rhodes GL, Ledgerwood DM, et al. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients. Exp Clin Psychopharmacol. 2009; 17:320325.
  • 13
    Higgins ST, Stoller K, Heil SH, eds. Contingency Management in Substance Abuse Treatment. New York, NY: Guilford Press; 2008.
  • 14
    Norregaard J, Tonnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med. 1993; 22:261271.
  • 15
    Paoletti P, Fornai E, Maggiorelli F, et al. Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. Eur Respir J. 1996; 9:643651.
  • 16
    Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978; 3:235241.
  • 17
    Gorber SC, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009; 11:1224.
  • 18
    Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health. 1994; 84:10861093.
  • 19
    Packer RR, Howell DN, McPherson S, et al. Investigating reinforcer magnitude and reinforcer delay: A contingency management analog study. Exp Clin Psychopharmacol. 2012; 20:287292.
  • 20
    Roll JM, Higgins ST, Badger GJ. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal. 1996; 29:495505.
  • 21
    Cropsey KL, Eldridge GD, Weaver MF, et al. Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res. 2006; 8:653659.
  • 22
    Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005; 100:159167.
  • 23
    Dallery J, Meredith S, Glenn IM. A deposit contract method to deliver abstinence reinforcement for cigarette smoking. J Appl Behav Anal. 2008; 41:609615.
  • 24
    Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86:11191127.
  • 25
    Corby EA, Roll JM, Ledgerwood DM, et al. Contingency management interventions for treating the substance abuse of adolescents: A feasibility study. Exp Clin Psychopharmacol. 2000; 8:371376.
  • 26
    Roll JM, Higgins ST. A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend. 2000; 58:103109.
  • 27
    Roll JM, Higgins ST, Steingard S, et al. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: A feasibility study. Exp Clin Psychopharmacol. 1998; 6:157161.
  • 28
    Roll JM, Howard JT. The relative contribution of economic valence to contingency management efficacy: A pilot study. J Appl Behav Anal. 2008; 41:629633.
  • 29
    Cooke F, Bullen C, Whittaker R, et al. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008; 10:607612.
  • 30
    Montalto NJ, Wells WO. Validation of self-reported smoking status using saliva cotinine: A rapid semiquantitative dipstick method. Cancer Epidemiol Biomarkers Prev. 2007; 16:18581862.
  • 31
    Podsakoff PM, MacKenzie SB, Lee JY, et al. Common method biases in behavioral research: A critical review of the literature and recommended remedies. J Appl Psychol. 2003; 88:879903.